Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, opens a panel discussion surrounding the treatment pathways for patients diagnosed with early breast cancer.
CDK 4/6 Inhibitors in High-Risk Early Breast Cancer
A panel of medical experts explore the impact of breast cancer diagnosis on patient quality of life and how the patient journey is navigated.
Key opinion leaders highlight unmet needs surrounding the treatment of breast cancer.
Drs Hanna, Mullangi, Sammons, and McArthur provide insight on changes in breast cancer treatment strategies.
Jay Andersen, MD, shares his perspective on breast cancer treatment and potential barriers to care.
Breast cancer experts discuss the role of biomarker testing in patients who receive a disease diagnosis.
Medical experts discuss cost perspectives in selecting breast cancer treatments.
Medical experts discuss strategies to optimize treatment adherence for patients diagnosed with breast cancer.
Dr Hanna drives a discussion regarding breast cancer treatments that have developed resistance to CDK 4/6 inhibitors.
A panel of medical experts discuss cost-effective treatment strategies.
This expert panel discusses significant opportunities for education and awareness of early breast cancer.
Advertisement
Advertisement
Trending on AJMC
1
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
2
Opposing Sides of 340B Debate Converge on Data Clearinghouse, Patient Definition
3
Health System Pharmacies Keep Patients on GLP-1 Therapy
4
Community Oncologists Ready to Innovate, but Barriers Remain
5